콜드체인 의약품 시장 : 의약품, 서비스, 온도 범위, 운송 - 세계 예측(2025-2030년)

The Cold-chain Pharma Market was valued at USD 7.89 billion in 2023, expected to reach USD 8.85 billion in 2024, and is projected to grow at a CAGR of 12.65%, to USD 18.18 billion by 2030.

The cold-chain pharma market encompasses the logistics, storage, and transportation systems designed to maintain pharmaceutical products at designated low temperatures. Its necessity is rooted in preserving the efficacy and quality of temperature-sensitive drugs, vaccines, and biologics. Critical applications include vaccine distribution, biopharmaceuticals, and clinical trial materials, with end-users ranging from hospitals to research labs and retail pharmacies. The market is forecasted for substantial growth driven by increased global demand for biopharmaceuticals and complex biologics, coupled with heightened attention to regulatory compliance and quality standards. The rising prevalence of chronic diseases and the global push for immunization contribute significantly to this growth, alongside technological advancements in IoT and AI-powered monitoring systems aiding real-time data tracking and predictive analytics. However, the sector faces limitations such as high operational costs, limited infrastructure in developing regions, and stringent regulatory landscapes, which pose challenges to seamless expansion.

A substantial opportunity lies in expanding the cold chain infrastructure in emerging markets and developing more sustainable, energy-efficient technologies to minimize carbon footprints. There is an opening for innovation in biosensing packaging and blockchain-based traceability solutions, offering enhanced supply chain transparency and security. Market players should also explore advancements in AI and machine learning for predictive maintenance and route optimization to reduce logistics costs. Challenges include addressing the gap in skilled workforce and adapting to rapid technological changes while ensuring quality and safety compliance. Industry participants should invest in training and development programs and foster partnerships with tech firms to leverage next-gen technologies. By focusing on robust, adaptable strategies and sustainable practices, businesses can capitalize on burgeoning opportunities to solidify market positioning. Continuous research into eco-friendly materials and cost-effective, scalable solutions will ensure resilience and competitiveness in this dynamic landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cold-chain Pharma Market

The Cold-chain Pharma Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing demand for storage of temperature-sensitive drugs and products
  • Stringent government regulations for pharmaceutical product storage and transportation
  • Increasing government initiatives for R&D activities
• Market Restraints
  • High cost of execution for cold storage areas and maintenance
• Market Opportunities
  • Advancement in vaccine development, monoclonal antibodies, and biologics
  • Integration of IoT and blockchain in pharma cold chain
• Market Challenges
  • Operational complexity of pharmaceutical cold chain logistics and lack of skilled professional

Porter's Five Forces: A Strategic Tool for Navigating the Cold-chain Pharma Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cold-chain Pharma Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cold-chain Pharma Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cold-chain Pharma Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cold-chain Pharma Market

A detailed market share analysis in the Cold-chain Pharma Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cold-chain Pharma Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cold-chain Pharma Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cold-chain Pharma Market

A strategic analysis of the Cold-chain Pharma Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cold-chain Pharma Market, highlighting leading vendors and their innovative profiles. These include AGILITY LOGISTICS PRIVATE LIMITED by DSV A/S, AmerisourceBergen Corporation, Cavalier Logistics, Inc. by Mitsubishi Logistics, Continental AG, CWT Ltd., DB Schenker, Deutsche Post AG, DHL International GmbH, FedEx Corporation, HCL Technologies Limited, Helapet ltd., JWD InfoLogistics Public Co. Ltd., Keppel Telecommunications & Transportation Ltd,, Kerry Logistics Network Limited by SF Holding Co., Ltd., Kuehne + Nagel Management AG, OOCL Logistics Limited by COSCO SHIPPING Holdings Co. Limited, SCG Logistics Management Co Ltd., Tiong Nam Logistics Holdings Berhad, United Parcel Service, Inc., VersaCold Logistics Services, WHA Group, Ych Group, and Yusen Logistics Group.

Market Segmentation & Coverage

This research report categorizes the Cold-chain Pharma Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Pharma Product, market is studied across Biologics, Over-the-Counter Medicines, Prescribed Drugs, and Raw Materials & Bulk Pharmaceuticals.
• Based on Services, market is studied across Transportation and Warehousing & VAS.
• Based on Temperature Range, market is studied across Ambient and Refrigerated. The Refrigerated is further studied across Frozen, Liquid-Phase Liquid Nitrogen Conditions, Ultra-Frozen, and Vapour-Phase Liquid Nitrogen.
• Based on Transportation, market is studied across Air-ways, Road, and Sea-Ways.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing demand for storage of temperature-sensitive drugs and products
    • 5.1.1.2. Stringent government regulations for pharmaceutical product storage and transportation
    • 5.1.1.3. Increasing government initiatives for R&D activities
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of execution for cold storage areas and maintenance
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancement in vaccine development, monoclonal antibodies, and biologics
    • 5.1.3.2. Integration of IoT and blockchain in pharma cold chain
  • 5.1.4. Challenges
    • 5.1.4.1. Operational complexity of pharmaceutical cold chain logistics and lack of skilled professional
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cold-chain Pharma Market, by Pharma Product

• 6.1. Introduction
• 6.2. Biologics
• 6.3. Over-the-Counter Medicines
• 6.4. Prescribed Drugs
• 6.5. Raw Materials & Bulk Pharmaceuticals

7. Cold-chain Pharma Market, by Services

• 7.1. Introduction
• 7.2. Transportation
• 7.3. Warehousing & VAS

8. Cold-chain Pharma Market, by Temperature Range

• 8.1. Introduction
• 8.2. Ambient
• 8.3. Refrigerated
  • 8.3.1. Frozen
  • 8.3.2. Liquid-Phase Liquid Nitrogen Conditions
  • 8.3.3. Ultra-Frozen
  • 8.3.4. Vapour-Phase Liquid Nitrogen

9. Cold-chain Pharma Market, by Transportation

• 9.1. Introduction
• 9.2. Air-ways
• 9.3. Road
• 9.4. Sea-Ways

10. Americas Cold-chain Pharma Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cold-chain Pharma Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cold-chain Pharma Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AGILITY LOGISTICS PRIVATE LIMITED by DSV A/S
• 2. AmerisourceBergen Corporation
• 3. Cavalier Logistics, Inc. by Mitsubishi Logistics
• 4. Continental AG
• 5. CWT Ltd.
• 6. DB Schenker
• 7. Deutsche Post AG
• 8. DHL International GmbH
• 9. FedEx Corporation
• 10. HCL Technologies Limited
• 11. Helapet ltd.
• 12. JWD InfoLogistics Public Co. Ltd.
• 13. Keppel Telecommunications & Transportation Ltd,
• 14. Kerry Logistics Network Limited by SF Holding Co., Ltd.
• 15. Kuehne + Nagel Management AG
• 16. OOCL Logistics Limited by COSCO SHIPPING Holdings Co. Limited
• 17. SCG Logistics Management Co Ltd.
• 18. Tiong Nam Logistics Holdings Berhad
• 19. United Parcel Service, Inc.
• 20. VersaCold Logistics Services
• 21. WHA Group
• 22. Ych Group
• 23. Yusen Logistics Group